Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05140642 · ClinicalTrials.gov registry record · NA
Safety and Efficacy Study of AI LVEF
A NA study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 3,495
- Enrollment target
NCT05140642: Completed NA study, sponsored by Cedars-Sinai Medical Center.
NCT05140642 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 3,495 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (149% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05140642, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,495 participants
- Enrollment target
Study Summary
To determine whether an integrated AI decision support can save time and improve accuracy of assessment of echocardiograms, the investigators are conducting a blinded, randomized controlled study of AI guided measurements of left ventricular ejection fraction compared to sonographer measurements in preliminary readings of echocardiograms.
Primary Outcome
Proportion of studies the LVEF is changed more than 5% in final report
Interventions
- OTHER Automated annotation of the left ventricle through deep learning
- OTHER Sonographer Measurement of LVEF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,495 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2022-06-29 |
| Phase | NA |
What the finished NCT05140642 record still lists
NCT05140642 is an interventional study that assigns participants to a tested intervention. Its 3,495 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (149% higher).
The record links to 0 conditions, and to 2 interventions - of which Automated annotation of the left ventricle through deep learning is the first listed.
NCT05140642 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05140642 about?
NCT05140642 is a clinical study titled "Safety and Efficacy Study of AI LVEF". To determine whether an integrated AI decision support can save time and improve accuracy of assessment of echocardiograms, the investigators are conducting a blinded, randomized controlled study of AI guided measurements of left ventricular ejection fraction compared to sonographer measurements in ...
What is the current status of trial NCT05140642?
This trial is currently completed. It is a NA study. The enrollment target is 3,495 participants. The study started on 2022-04-01. Estimated completion is 2022-06-29.
What interventions are being tested in trial NCT05140642?
The interventions under investigation include: Automated annotation of the left ventricle through deep learning (OTHER), Sonographer Measurement of LVEF (OTHER).
Who is sponsoring clinical trial NCT05140642?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05140642's enrollment target sits among peer trials
3,495 37th of 2000 higher than 1,964 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260559 · 3,500 participants
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
- NCT01612949 · 3,500 participants
Facial Analysis to Classify Difficult Intubation
- NCT02398786 · 3,500 participants
Myotonic Dystrophy Family Registry
- NCT03486873 · 3,500 participants · Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI